Investigations of methylmercury-induced alterations in neurogenesis.
暂无分享,去创建一个
Elaine M Faustman | E. Faustman | R. Ponce | Y. C. Ou | T. Kavanagh | T. Lewandowski | Rafael A Ponce | Ying C Ou | Ma Aileen C Mendoza | Thomas Lewandowski | Terrance Kavanagh | Magdalena Mendoza
[1] D. Rice,et al. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.
[2] E. Faustman,et al. Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. , 1999, Toxicology and applied pharmacology.
[3] R. Paules,et al. Cell cycle control, checkpoint mechanisms, and genotoxic stress. , 1999, Environmental health perspectives.
[4] S. Orrenius,et al. Thiol modification and cell signalling in chemical toxicity. , 1992, Toxicology letters.
[5] W. Hughes. A PHYSICOCHEMICAL RATIONALE FOR THE BIOLOGICAL ACTIVITY OF MERCURY AND ITS COMPOUNDS , 1957, Annals of the New York Academy of Sciences.
[6] M. Aschner,et al. Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. , 1984, Neurobehavioral toxicology and teratology.
[7] T. Clarkson,et al. Metal toxicity in the central nervous system. , 1987, Environmental health perspectives.
[8] L. Lapham,et al. ABNORMAL NEURONAL MIGRATION, DERANGED CEREBRAL CORTICAL ORGANIZATION, AND DIFFUSE WHITE MATTER ASTROCYTOSIS OF HUMAN FETAL BRAIN: A MAJOR EFFECT OF METHYLMERCURY POISONING IN UTERO , 1978, Journal of neuropathology and experimental neurology.
[9] L. Philipson,et al. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. , 1994, Genes & development.
[10] A. Verhoef,et al. The early effects of methylmercury on the developing rat brain , 2004, Acta Neuropathologica.
[11] K. McGinnis,et al. Methylmercury increases intracellular concentrations of Ca++ and heavy metals in NG108-15 cells. , 1993, The Journal of pharmacology and experimental therapeutics.
[12] K. Prasad,et al. Alterations in gene expression after chronic treatment of glioma cells in culture with methylmercuric chloride. , 1979, Biochemical pharmacology.
[13] P. Sager. Selectivity of methyl mercury effects on cytoskeleton and mitotic progression in cultured cells. , 1988, Toxicology and applied pharmacology.
[14] S H Moolgavkar,et al. A biologically-based dose-response model for developmental toxicology. , 1996, Risk analysis : an official publication of the Society for Risk Analysis.
[15] K. Eto. Pathology of Minamata disease. , 1997, Toxicologic pathology.
[16] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[17] Choi Bh. Methylmercury poisoning of the developing nervous system: I. Pattern of neuronal migration in the cerebral cortex. , 1986 .
[18] N. Holbrook,et al. Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. , 1992, The Journal of biological chemistry.
[19] A. Fornace,et al. The p53-dependent gamma-ray response of GADD45. , 1994, Cancer research.
[20] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.
[21] E. Faustman,et al. The role of intracellular glutathione in methylmercury-induced toxicity in embryonic neuronal cells. , 1999, Neurotoxicology.
[22] M. Karin,et al. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.
[23] B. H. Choi. Effects of methylmercury on neuroepithelial germinal cells in the developing telencephalic vesicles of mice , 2004, Acta Neuropathologica.
[24] N. Herschkowitz,et al. Brain development in the fetus, neonate and infant. , 1988, Biology of the neonate.
[25] C. Guillouf,et al. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. , 1995, Oncogene.
[26] P. Rabinovitch,et al. BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis. , 1988, Experimental cell research.
[27] E. Faustman,et al. p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure. , 2002, Toxicology and applied pharmacology.
[28] M. Karin,et al. AP-1 in cell proliferation and survival , 2001, Oncogene.
[29] B. H. Choi. The effects of methylmercury on the developing brain , 1989, Progress in Neurobiology.
[30] M. Fiscella,et al. A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress * , 1995, The Journal of Biological Chemistry.
[31] J. Fargnoli,et al. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents , 1989, Molecular and cellular biology.
[32] C. Pickart,et al. Mechanism of ubiquitin conjugating enzyme E2-230K: catalysis involving a thiol relay? , 1996, Biochemistry.
[33] James Brugarolas,et al. Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.
[34] R. Cuesta,et al. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.
[35] D. Ron,et al. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. , 1992, Genes & development.
[36] N. Mottet,et al. Effects of methylmercury on the morphogenesis of the rat cerebellum. , 1986, Teratology.
[37] E. Faustman,et al. Biologically based dose-response models for developmental toxicants: lessons from methylmercury. , 1999, Inhalation toxicology.
[38] M. Harada,et al. Congenital Minamata disease: intrauterine methylmercury poisoning. , 1978, Teratology.
[39] Bert Vogelstein,et al. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.
[40] P. Howley,et al. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.
[41] N. Mottet. Effects of chronic low-dose exposure of rat fetuses to methylmercury hydroxide. , 1974, Teratology.
[42] E. Faustman,et al. Effects of methyl mercury on the cell cycle of primary rat CNS cells in vitro. , 1994, Toxicology and applied pharmacology.
[43] N. Imura,et al. Effects of methylmercury on mitotic mouse glioma cells. , 1978, Environmental research.
[44] S. Bayer. Cellular aspects of brain development. , 1989, Neurotoxicology.
[45] M. Verity,et al. Oxidative mechanisms underlying methyl mercury neurotoxicity , 1991, International Journal of Developmental Neuroscience.
[46] T W Clarkson,et al. Reproductive and developmental toxicity of metals. , 1985, Scandinavian journal of work, environment & health.
[47] N. Mottet,et al. The Congenital Teratogenicity and Perinatal Toxicity of Metals , 1983 .
[48] K. Eto,et al. Review Article: Pathology of Minamata Disease , 1997 .
[49] B. Weiss,et al. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. , 1990, Neurotoxicology and teratology.
[50] E. Faustman,et al. Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury. , 1997, Toxicology and applied pharmacology.
[51] E. Faustman,et al. Characterization of cytoskeletal and neuronal markers in micromass cultures of rat embryonic midbrain cells , 1993, Cell Biology and Toxicology.
[52] P. O'Connor,et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.
[53] C. Cox,et al. Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. , 1987, Archives of neurology.
[54] M. Hochstrasser. Ubiquitin-dependent protein degradation. , 1996, Annual review of genetics.
[55] S. Elledge,et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.
[56] E. Sausville,et al. Proteasome inhibitors: a novel class of potent and effective antitumor agents. , 1999, Cancer research.
[57] T. Horigome,et al. Alterations in Gene Expression Due to Methylmercury in Central and Peripheral Nervous Tissues of the Rat , 1991 .
[58] William D. Atchison,et al. Mechanisms of methylmercury‐induced neurotoxicity , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[59] W. Mundy,et al. Sensitivity of immature neurons in culture to metal-induced changes in reactive oxygen species and intracellular free calcium. , 2000, Neurotoxicology.
[60] W. Atchison,et al. Methylmercury alters intrasynaptosomal concentrations of endogenous polyvalent cations. , 1993, Toxicology and applied pharmacology.
[61] M. Berridge,et al. Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[62] T Takeuchi,et al. FETAL MINAMATA DISEASE: A NEUROPATHOLOGICAL STUDY OF TWO CASES OF INTRAUTERINE INTOXICATION BY A METHYL MERCURY COMPOUND , 1965, Journal of neuropathology and experimental neurology.
[63] M. Aschner,et al. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. , 1984, Brain research.
[64] Y. Takizawa,et al. A fetal type of Minamata disease. An autopsy case report with special reference to the nervous system. , 1992, Molecular and chemical neuropathology.
[65] A. Fornace,et al. DNA damage-inducible transcripts in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Osame,et al. Computed tomography in fetal methylmercury poisoning. , 1993, Journal of toxicology. Clinical toxicology.
[67] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[68] A. Fornace,et al. The p53-dependent γ-Ray Response of GADD45 , 1994 .
[69] E. Mcgeer,et al. Methylmercury poisoning of the developing nervous system in the rat: decreased activity of glutamic acid decarboxylase in cerebral cortex and neostriatum. , 1985, Brain research.
[70] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[71] E. Wagner,et al. Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.